Medico Remedies

Medico_Remedies29 Apr 2024

Pharmaceuticals

₹

-0.61 (-1.31%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Medico Remedies

Medico Remedies

Pharmaceuticals

Medico_Remedies29 Apr 2024

₹

-0.61 (-1.31%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
02-Feb-2023	S	Medico Remedies Limited has informed the Exchange that the Board of Directors at its meeting held on February 02, 2023, has considered and approved subdivision of 16596800 equity shares of 10 each into 82984000 equity shares of 2 each. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 2nd February, 2023 has, inter alia considered and approved the following: 1. Sub-division/ Stock Split of equity shares of the Company 2. Notice of Postal Ballot Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 2nd February, 2023 has, inter alia considered and approved the following: 1. Sub-division/ Stock Split of equity shares of the Company (As Per BSE Announcement Dated on 02.02.2023) With reference to the above cited subject, we would like to inform to the exchange that Board of the Directors of the Company have fixed Thursday, 16th March, 2023 as the 'Record Date' for ascertaining eligibility of shareholders entitled for corporate action of - 1. Sub-division/split of 1 (One) equity shares of face value Rs. 10/- (Rupees Ten Only) each fully paid up into 5 (Five) equity shares of Rs. 2/- (Rupees Two Only) each fully paid up. (As per BSE Announcement Dated on 04/03/2023) Trading Members of the Exchange are hereby informed that MEDICO REMEDIES LIMITED, has fixed Record Date for the purpose of Sub-Division of the Equity Shares of the Company :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE MEDICO REMEDIES LIMITED (540937) RECORD DATE 16.03.2023 PURPOSE Subdivision of the existing Equity Shares from One Equity Share of Rs.10/- each into Five Equity Shares of Rs.2/- each. SUB-DIVIDED PAID-UP VALUE Rs.2/- SUB-DIVIDED PAID-UP VALUE W.E.F. 16/03/2023 DR-740/2022-2023 Note:- i. ISIN No. INE630Y01016 of Rs. 10/- paid up will not be valid for transactions done on the Exchange on or after 16/03/2023. ii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 08.03.2023) This is in continuation to our communication dated 04th March, 2023 with respect to Sub-Division of Equity Share fully paid up with effect from March 16, 2023(Record Date). Please be informed that the Sub- Division of Equity Shares will take effect under the new ISIN i.e. INE630Y01024. (As Per BSE Announcement dated on 10.03.2023) In Continuation of Notice No. 20230308-21 dated March 08, 2023, Trading Members of the Exchange are hereby informed that the New ISIN number for the Sub-Divided Equity Shares of the Company will be as under: - Company Name & Scrip Code MEDICO REMEDIES LIMITED (540937) New ISIN No. INE630Y01024 Remarks Sub-division of Equity Shares from Rs.10/- to Rs.2/- The new ISIN number given above, for Equity Shares of Rs.2/- each of the Company shall be effective for trades done on and from the Ex-Date i.e. 16-03-2023 (DR-740/2022-2023) (As Per BSE Notice Dated on 14.03.2023)	16-Mar-2023
10-Nov-2021	B	3:1 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, MEDICO REMEDIES LIMITED has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date: DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE MEDICO REMEDIES LIMITED (540937) RECORD DATE 17/11/2021 PURPOSE Issue of 03 (Three) Bonus equity shares of Rs.10/- each for every 01 (One) existing equity share of Rs.10/- each held. Ex-Bonus basis from Date & Sett. No. 16/11/2021 DR-157/2021-2022 Trading Members are requested to note the change in the market lot of MEDICO REMEDIES LIMITED (540937) pursuant to the Bonus Issue of equity shares as given below, which will be effective from Tuesday, November 16, 2021: Scrip Code 540937 Scrip Name MEDICO REMEDIES LIMITED Current Market Lot 600 Revised Market Lot 1200 (As Per BSE Notice Dated on 15.11.2021)	17-Nov-2021	3:1
30-Jan-2024	BC	Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve Unaudited Financial Results for the Quarter	12-Feb-2024
10-Jan-2024	BC	Harshit Haresh Mehta	09-Jan-2024
10-Jan-2024	BC	Rishit Haresh Mehta	09-Jan-2024
10-Jan-2024	BC	Haresh Kapurlal Mehta	09-Jan-2024
31-Oct-2023	BC	Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Unaudited Financial Results for the quarter	09-Nov-2023

No Rights has been declared by Medico_Remedies

Book Closure

Record Date	Split Date	Purpose
12-Feb-2024	-	Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve Unaudited Financial Results for the Quarter
09-Jan-2024	-	Harshit Haresh Mehta
09-Jan-2024	-	Rishit Haresh Mehta
09-Jan-2024	-	Haresh Kapurlal Mehta
09-Nov-2023	-	Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Unaudited Financial Results for the quarter

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Medico Remedies Ltd ₹45.94(-0.61/-1.31%)	45.94	-0.61	381.23	-41.90	54.69	8.01
Astrazeneca Pharma India Ltd ₹5,556.10(+140.70/2.60%)	5,556.10	+140.70	13,890.25	71.09	87.09	21.21
Bliss GVS Pharma Ltd ₹124.45(+1.85/1.51%)	124.45	+1.85	1,302.88	60.79	19.09	1.33
Cipla Ltd ₹1,407.55(-1.85/-0.13%)	1,407.55	-1.85	113,644.88	54.54	34.56	4.39
Abbott India Ltd ₹26,277.60(+412.75/1.60%)	26,277.60	+412.75	55,839.90	15.87	48.74	17.96
Amrutanjan Health Care Ltd ₹709.40(+28.55/4.19%)	709.40	+28.55	2,050.92	13.21	46.61	7.83

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	29.77	42.36	31.47	27.99	38.85	40.46
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	29.77	42.36	31.47	27.99	38.85	40.46
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.27	0.96	0.31	0.04	0.86	1.55
Total Income	30.05	43.31	31.78	28.03	39.71	42.01
Total Expenditure	27.04	39.28	29.02	24.83	35.46	37.32
PBIDT	3.01	4.03	2.77	3.21	4.25	4.70
Interest	0.22	0.18	0.17	0.21	0.20	0.17
PBDT	2.78	3.85	2.60	3.00	4.05	4.52
Depreciation	0.72	0.71	0.71	0.73	0.74	0.66
Tax	0.67	0.71	0.59	0.44	1.06	0.82
Deferred Tax	-0.05	0.00	-0.03	0.07	0.01	0.17
Reported Profit After Tax	1.45	2.43	1.32	1.77	2.25	2.87
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	1.45	2.43	1.32	1.77	2.25	2.87

EPS (Unit Curr.)	0.17	0.29	0.16	0.21	1.36	1.73
EPS (Adj) (Unit Curr.)	0.17	0.29	0.16	0.21	0.27	0.35
Calculated EPS (Unit Curr.)	0.35	0.58	0.32	0.21	1.36	1.73
Calculated EPS (Adj) (Unit Curr.)	0.35	0.58	0.32	0.21	0.27	0.35
Calculated EPS (Ann.) (Unit Curr.)	1.39	2.34	1.27	0.85	5.42	6.91
Calculated EPS (Adj) (Ann.) (Unit Curr.)	1.39	2.34	1.27	0.85	1.08	1.38
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	8.30	8.30	8.30	16.60	16.60	16.60
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	10.11	9.51	8.80	11.47	10.94	11.62
PBDTM(%)	9.34	9.09	8.26	10.72	10.42	11.17
PATM(%)	4.87	5.74	4.19	6.32	5.79	7.09

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	16.60	16.60	4.15	4.15	4.15	4.15
Reserves Total	27.25	19.98	28.31	25.72	24.09	22.52
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	43.85	36.58	32.46	29.87	28.24	26.67
Secured Loans	7.85	10.37	12.79	13.04	11.14	10.52
Unsecured Loans	1.92	2.23	2.26	0.83	2.38	2.03
Total Debt	9.77	12.60	15.05	13.87	13.52	12.55
Total Liabilities	53.62	49.18	47.51	43.74	41.76	39.22
APPLICATION OF FUNDS :
Gross Block	39.35	32.39	28.87	24.36	22.43	15.37
Less : Accumulated Depreciation	17.52	14.36	13.56	11.82	10.17	8.74
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	21.83	18.03	15.31	12.54	12.26	6.63
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.07	0.00	0.00	2.28	0.90	4.37
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	1.17	0.15	0.15	0.24
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	19.70	18.11	14.55	18.26	16.07	14.91
Sundry Debtors	36.09	30.39	27.42	23.89	29.07	17.01
Cash and Bank	2.18	2.34	2.83	1.42	0.61	0.81
Loans and Advances	6.57	6.73	12.62	13.07	13.43	12.96
Total Current Assets	64.54	57.58	57.42	56.64	59.18	45.69
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	32.41	27.70	27.68	31.30	34.30	19.81
Provisions	0.90	0.41	0.17	0.01	0.00	0.00
Total Current Liabilities	33.31	28.11	27.85	31.30	34.30	19.81
Net Current Assets	31.23	29.47	29.57	25.34	24.89	25.88
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.01	0.25	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.19	0.07	0.16	0.22	0.18	0.12
Net Deferred Tax	-0.18	0.18	-0.16	-0.22	-0.18	-0.12
Total Assets	52.95	47.68	45.89	40.10	38.02	37.00
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	1.17	2.83	0.00	0.16	0.21
Net Cash from Operating Activities	8.17	5.86	-11.31	0.97	4.94
Net Cash Used In Investing Activities	-6.60	-1.76	-16.96	-3.08	-4.43
Net Cash Used In Financing Activities	-1.82	-5.77	18.28	2.60	-0.55
Net Inc./Dec In Cash And Cash Equivalents	-0.25	-1.67	-9.99	0.48	-0.04
Cash And Cash Equivalents At End Of The Year	0.91	1.17	-9.99	0.65	0.16

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

73.34%

FII Shareholding

0.29%

DII Shareholding

0.74%

Public Shareholding

25.63%

**Promoter pledged shareholding 73.34%

About Medico Remedies Ltd

Medico Remedies Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 381.23 crores. It has reported a sales of Rs. 29.77 crores and a net profit of Rs. 1.45 crores for the quarter ended December 2018. The company management includes Haresh Mehta, Haresh Mehta,Harshit Mehta,Rita Mehta,Rishit Mehta,Deepak Vekaria,Ramesh Rughani,Bharat Rathod,Dinesh Modi,Deepesh Shah (Medico Remedies Ltd) among others.

Chairman

Haresh Mehta

Registered office

1105/1106 11-Flr Hubtown Solar,N S Phadke Marg Andheri East,Mumbai,Maharashtra,400069

FAX :

Background

Incorporation Year1994

Face Value₹2

Market Lot1

How to buy Medico Remedies shares on nse?

To buy Medico Remedies shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Medico Remedies share price today?

The Medico Remedies shares price on nse is Rs.45.94 today.

What is the market cap of Medico Remedies shares on BSE ?

The company has a market capitalization of Rs.381.23Cr

What is the PE & PB ratio of Medico Remedies shares ?

PE is 54.69 and PB is 8.01

What is the 52 Week High and Low of Medico Remedies shares?

Medico Remedies stock price high: Rs.100.79 Medico Remedies stock price low: Rs.44.53